Help Me Cross The Finish Line in Maui!!
After a long break due to the pandemic, I will be racing in orange once again-this time in beautiful Maui, Hawaii! Many know I have struggled greatly with my health over the years and I am so thankful that I am healthy enough to participate in Team Challenge on behalf of those who are not. However, I do hope that one day my friends and I will be able to say we 'had' IBD because the reality of having an incurable disease is there daily, whether or not we are in remission. We can't do that without your generous help that will fund reserach to discover more effective, safe treatments, and hopefully one day a CURE!! I am so exctied for this race and would be so grateful for your support! Thank you so much!! :)
About Crohn’s disease and ulcerative colitis
Known collectively as inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis affects almost 1 in 100 people. They are painful, medically incurable diseases that attack the digestive system. Crohn's disease may attack anywhere along the digestive tract, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, persistent diarrhea, rectal bleeding, fever, and weight loss. Many patients require numerous hospitalizations and surgery. Most people develop the diseases between the ages of 15 and 35; however the incidence is increasing in children.
The Crohn's & Colitis Foundation is the largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD). The Foundation’s mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who are affected by these diseases. The Foundation works to fulfill its mission by funding research; providing educational resources for patients and their families, medical professionals, and the public; and furnishing supportive services for those afflicted with IBD.
AchievementsNo Badges Have Been Earned
Fundraising Honor Roll
Chloe & Kim
If you think this page contains objectionable content, please inform the system administrator.